Bio Medica Laboratories share news and announcements
NSE: BMLLPharmaceuticals & Biotechnology
Share price at the NSE close on 23 Oct 2026. Previous close ₹155.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹188 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 27 Jul 2026
- 16.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 27 Jul 2026
- 44.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Jul 2026
- 0.87
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 50,000100.0% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Bio Medica Laboratories half-yearly results
The board met on 27 Jul 2026 to consider financial results and other business matters
Notice filed 22 Jul 2026
Bio Medica Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Bio Medica Laboratories financials, year by year
Annual reports1
Bio Medica Laboratories share news and announcements
26 announcements, routine notices left out, newest first.
Sep 2026
2 Sep · Corporate action
2 Sep · Board meeting
Aug 2026
14 Aug · Board meeting
13 Aug · Management
13 Aug · Management
13 Aug · Management
Jul 2026
28 Jul · Meeting
28 Jul · Meeting
Jun 2026
23 Jun · Meeting
22 Jun · Amendment to AOA/MOA
22 Jun · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 13 Aug 2026Board or managers changedup 1.21%+1.3 pts vs Nifty 500market median 0.0% · five sessions +9.9% (+11.1 pts vs Nifty 500) · volume 2.2× usual · The announcement (opens in a new tab)
- 28 Jul 2026Resultsdown 0.28%−0.1 pts vs Nifty 500market median −0.7% · five sessions +11.7% (+8.9 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
Bio Medica Laboratories results filing dates and deadlines
Listed companies must file half-yearly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.